News | October 27, 2021
Cipla consolidated net profit at Rs 711.36 cr. in Q2FY22
Cipla has reported consolidated financial results for the period ended September 30, 2021
Cipla has reported consolidated financial results for the period ended September 30, 2021
It answers the most basic questions from a patient’s perspective
A total of 12 generic medicines have been included in the list
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
If cleared, Merck's drug would be the first pill shown to treat Covid-19, a potentially major advance in efforts to fight the pandemic
The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes
Subscribe To Our Newsletter & Stay Updated
